Bali Muralidhar

Managing Partner, Chief Investment Officer

London, England, United Kingdom

74 investments

Bali Muralidhar is a Managing Partner, Chief Investment Officer at Abingworth based in London, England, United Kingdom. Bali Muralidhar has backed 74 companies, including Kesios Therapeutics, Spruce Biosciences and Amarin. Investment focus areas include Health Care, Women Founded and Life Science.

Investment Focus

Health and Hospital Services

Media and Entertainment

Pharmaceuticals

Portfolio Companies (73)


1	Kesios Therapeutics
2	Spruce Biosciences
3	Amarin
4	Syntaxin
5	CRISPR Therapeutics
6	Attenua
7	Broncus Technologies
8	Jasper Therapeutics
9	Synosia Therapeutics
10	X4 Pharmaceuticals
11	Kspine
12	Anjarium Biosciences

Showing 1–12 of 73

Page 1 of 7

Access Full Contact Information

Get Bali Muralidhar's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.

Portfolio

3-day free trial, cancel anytime

Raising a round? Run your numbers first

Free tools founders use before pitching investors like this one.

Runway calculatorHow long your cash lasts Burn rate calculatorMonthly spend, gross and net Funding goal calculatorHow much to raise Investor ROI calculatorWhat your investors earn Pitch deck template11 slides that close Fundraising playbookThe 7-step raise process